| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Pathology and Laboratory Medicine, 2 Pediatrics, 3 Hematology/Oncology, and 4 Neurosurgery, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia; and 5 Department of Neurological Surgery and the Brain Tumor Research Center, University of California-San Francisco, San Francisco, California
Requests for reprints: Daniel J. Brat, Department of Pathology and Laboratory Medicine, Emory University Hospital, H-176, 1364 Clifton Road Northeast, Atlanta, GA 30322. Phone: 404-712-1266; Fax: 404-727-3133; E-mail: dbrat{at}emory.edu.
We have previously proposed that intravascular thrombosis and subsequent vasoocclusion contribute to the development of pseudopalisading necrosis, a pathologic hallmark that distinguishes glioblastoma (WHO grade 4) from lower grade astrocytomas. To better understand the potential prothrombotic mechanisms underlying the formation of these structures that drive tumor angiogenesis, we investigated tissue factor (TF), a potent procoagulant protein known to be overexpressed in astrocytomas. We hypothesized that PTEN loss and tumor hypoxia, which characterize glioblastoma but not lower grade astrocytomas, could up-regulate TF expression and cause intravascular thrombotic occlusion. We examined the effect of PTEN restoration and hypoxia on TF expression and plasma coagulation using a human glioma cell line containing an inducible wt-PTEN cDNA. Cell exposure to hypoxia (1% O2) markedly increased TF expression, whereas restoration of wt-PTEN caused decreased cellular TF. The latter effect was at least partially dependent on PTEN's protein phosphatase activity. Hypoxic cells accelerated plasma clotting in tilt tube assays and this effect was prevented by both inhibitory antibodies to TF and plasma lacking factor VII, implicating TF-dependent mechanisms. To further examine the genetic events leading to TF up-regulation during progression of astrocytomas, we investigated its expression in a series of human astrocytes sequentially infected with E6/E7/human telomerase, Ras, and Akt. Cells transformed with Akt showed the greatest incremental increase in hypoxia-induced TF expression and secretion. Together, our results show that PTEN loss and hypoxia up-regulate TF expression and promote plasma clotting by glioma cells, suggesting that these mechanisms may underlie intravascular thrombosis and pseudopalisading necrosis in glioblastoma.
Key Words: Glioma astrocytoma thrombosis tissue factor hypoxia PTEN necrosis brain tumor
This article has been cited by other articles:
![]() |
C. Milsom, N. Magnus, B. Meehan, K. Al-Nedawi, D. Garnier, and J. Rak Tissue Factor and Cancer Stem Cells: Is There a Linkage? Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2005 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boccaccio and P. M. Comoglio Genetic Link Between Cancer and Thrombosis J. Clin. Oncol., October 10, 2009; 27(29): 4827 - 4833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Regina, J.-B. Valentin, S. Lachot, E. Lemarie, J. Rollin, and Y. Gruel Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN Clin. Chem., October 1, 2009; 55(10): 1834 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Narita, S. Yin, C. F. Gelin, C. S. Moreno, M. Yepes, K.C. Nicolaou, and E. G. Van Meir Identification of a Novel Small Molecule HIF-1{alpha} Translation Inhibitor Clin. Cancer Res., October 1, 2009; 15(19): 6128 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Provencal, D. Labbe, R. Veitch, D. Boivin, G.-E. Rivard, H. Sartelet, Y. Robitaille, D. Gingras, and R. Beliveau c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration Carcinogenesis, July 1, 2009; 30(7): 1089 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Barginear, M. Lesser, M. L. Akerman, M. Strakhan, I. Shapira, T. Bradley, and D. R. Budman Need for Inferior Vena Cava Filters in Cancer Patients: A Surrogate Marker for Poor Outcome Clinical and Applied Thrombosis/Hemostasis, June 1, 2009; 15(3): 263 - 269. [Abstract] [PDF] |
||||
![]() |
Y. Rong, V. E. Belozerov, C. Tucker-Burden, G. Chen, D. L. Durden, J. J. Olson, E. G. Van Meir, N. Mackman, and D. J. Brat Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity Cancer Res., March 15, 2009; 69(6): 2540 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Milsom, J. L. Yu, N. Mackman, J. Micallef, G. M. Anderson, A. Guha, and J. W. Rak Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and Angiogenesis Cancer Res., December 15, 2008; 68(24): 10068 - 10076. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dey, H. E. Crosswell, P. De, R. Parsons, Q. Peng, J. D. Su, and D. L. Durden The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration Cancer Res., March 15, 2008; 68(6): 1862 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Falanga and F. R. Rickles Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies Hematology, January 1, 2007; 2007(1): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rak, J. L. Yu, J. Luyendyk, and N. Mackman Oncogenes, Trousseau Syndrome, and Cancer-Related Changes in the Coagulome of Mice and Humans. Cancer Res., November 15, 2006; 66(22): 10643 - 10646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koizume, M.-S. Jin, E. Miyagi, F. Hirahara, Y. Nakamura, J.-H. Piao, A. Asai, A. Yoshida, E. Tsuchiya, W. Ruf, et al. Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII Cancer Res., October 1, 2006; 66(19): 9453 - 9460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rong, F. Hu, R. Huang, N. Mackman, J. M. Horowitz, R. L. Jensen, D. L. Durden, E. G. Van Meir, and D. J. Brat Early Growth Response Gene-1 Regulates Hypoxia-Induced Expression of Tissue Factor in Glioblastoma Multiforme through Hypoxia-Inducible Factor-1-Independent Mechanisms. Cancer Res., July 15, 2006; 66(14): 7067 - 7074. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kaur, F. W. Khwaja, E. A. Severson, S. L. Matheny, D. J. Brat, and E. G. Van Meir Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro-oncol, April 1, 2005; 7(2): 134 - 153. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |